Stine Krog Frandsen

Title: Stine Krog Frandsen: Innovator in Cancer Treatment

Introduction

Stine Krog Frandsen is a notable inventor based in Frederiksberg C, Denmark. She has made significant contributions to the field of cancer treatment through her innovative research and patents. Her work focuses on therapeutic applications that utilize calcium electroporation to effectively induce tumor necrosis.

Latest Patents

Stine Krog Frandsen holds 1 patent for her invention titled "Therapeutic applications of calcium electroporation to effectively induce tumor necrosis." This patent reveals that electroporation with calcium ions is efficient on cutaneous and subcutaneous nodules. The invention discloses that a solution comprising calcium ions (Ca) with a concentration of at least 0.1 M is extremely useful in treating neoplasms, such as cancer. The method involves causing transient permeabilization of the cell membranes of at least part of the neoplasm before, during, and/or after the administration of the solution, which is administered at a ratio of 0.2 to 0.8 of the volume of the neoplasm.

Career Highlights

Stine Krog Frandsen is affiliated with Herlev Hospital, where she continues her research and development in cancer therapies. Her work has garnered attention for its potential to improve treatment outcomes for patients suffering from various forms of cancer.

Collaborations

Stine collaborates with esteemed colleagues, including Karen Julie Gehl and Jens Ole Eriksen, who contribute to her research endeavors and help advance the field of cancer treatment.

Conclusion

Stine Krog Frandsen's innovative work in the therapeutic applications of calcium electroporation represents a significant advancement in cancer treatment. Her contributions are paving the way for new methodologies that could enhance patient care and treatment efficacy.